Aurora Cannabis (NYSE:ACB) Stock Rating Reaffirmed by Stifel Nicolaus

Aurora Cannabis (NYSE:ACB)‘s stock had its “sell” rating reissued by investment analysts at Stifel Nicolaus in a note issued to investors on Thursday, The Fly reports. They presently have a $5.00 price target on the stock, down from their previous price target of $7.00. Stifel Nicolaus’ target price indicates a potential downside of 15.97% from the company’s current price.

A number of other research firms also recently commented on ACB. Compass Point initiated coverage on Aurora Cannabis in a report on Monday, July 8th. They set a “neutral” rating for the company. Zacks Investment Research raised Aurora Cannabis from a “sell” rating to a “hold” rating in a report on Thursday. ValuEngine raised Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Wednesday, August 21st. Bank of America downgraded Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 target price for the company. in a report on Thursday, July 18th. Finally, Piper Jaffray Companies set a $7.00 target price on Aurora Cannabis and gave the stock a “hold” rating in a report on Friday. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Aurora Cannabis currently has a consensus rating of “Buy” and an average target price of $8.23.

Aurora Cannabis stock opened at $5.95 on Thursday. The company has a quick ratio of 1.98, a current ratio of 1.52 and a debt-to-equity ratio of 0.09. Aurora Cannabis has a 52 week low of $4.58 and a 52 week high of $12.52. The company has a market capitalization of $6.01 billion, a price-to-earnings ratio of -27.05 and a beta of 2.47. The stock has a 50-day moving average price of $6.06 and a 200 day moving average price of $7.66.

Several hedge funds have recently made changes to their positions in ACB. Mackey Komara & Dankovich LLC purchased a new stake in shares of Aurora Cannabis during the second quarter worth approximately $27,000. Executive Wealth Management LLC increased its position in shares of Aurora Cannabis by 102.1% during the second quarter. Executive Wealth Management LLC now owns 3,900 shares of the company’s stock worth $30,000 after purchasing an additional 1,970 shares in the last quarter. Kistler Tiffany Companies LLC increased its position in shares of Aurora Cannabis by 77.9% during the second quarter. Kistler Tiffany Companies LLC now owns 4,075 shares of the company’s stock worth $32,000 after purchasing an additional 1,785 shares in the last quarter. Resources Investment Advisors LLC. increased its position in shares of Aurora Cannabis by 825.7% during the second quarter. Resources Investment Advisors LLC. now owns 4,962 shares of the company’s stock worth $39,000 after purchasing an additional 4,426 shares in the last quarter. Finally, Manchester Financial Inc. purchased a new stake in shares of Aurora Cannabis during the second quarter worth approximately $43,000. 8.88% of the stock is owned by institutional investors and hedge funds.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Article: Dividend Aristocrat Index

The Fly

Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.